低剂量CT肺癌筛查中的支气管扩张
在2010至2019年纳入前瞻性Mount Sinai ELCAP筛查研究的2191名吸烟者中,低剂量CT检出支气管扩张者504人(23%),ELCAP支气管扩张评分中位数为12分;年龄较大、既往吸烟、自报慢阻肺、膈肌抬高或实变者支气管扩张更常见,且评分越高,2年内呼吸道症状和急性事件越频繁。
要点
- 低剂量CT筛查吸烟者中支气管扩张检出率高达23%,阅片时应主动评估。
- ELCAP评分越高,2年内呼吸道症状、急性事件及需住院事件越频繁(趋势P<.005)。
- 下叶最常受累,但ELCAP评分最高四分位组中肺受累比例(98%)高于下叶(93%)。
核心结论
- 吸烟者低剂量CT筛查中支气管扩张患病率较高,且随ELCAP支气管扩张评分加重,呼吸道症状和急性事件更频繁。
研究设计与样本
- 对2010至2019年前瞻性Mount Sinai ELCAP筛查研究中40-90岁吸烟者的低剂量CT进行二次阅片,采用ELCAP支气管扩张评分(0-42分,分值越高越重),并回顾低剂量CT后2年病历。
关键影像表现/征象
- 支气管扩张在所有参与者中最常见于下叶,且ELCAP评分越高下叶患病率越高(如评分16-42分时下叶患病率91%)。
- 在第四四分位组中,中肺受累比例高于下肺(131人中128人[98%] vs 131人中122人[93%])。
诊断标准与关键数值
- ELCAP支气管扩张评分为定量评分系统,范围0-42分,分值越高表示支气管扩张越严重。
- 共评估2191名参与者(平均年龄65岁±9;女性1140人[52%]),检出支气管扩张504人(23%),ELCAP评分中位数12分(四分位距9-16)。
临床应用与阅片要点
- 低剂量CT筛查时可按ELCAP评分评估支气管扩张的分布与严重程度,并注意中肺受累在重度病例中可高于下肺。
- 年龄每增加10岁(OR=2.0;95%CI:1.7,2.4)、既往吸烟(OR=1.33;95%CI:1.01,1.73)、自报慢阻肺(OR=1.38;95%CI:1.02,1.88)、膈肌抬高(OR=4;95%CI:2,11)或实变(OR=5;95%CI:3,11)者支气管扩张更常见。
- 超重(OR=0.7;95%CI:0.5,0.9)或肥胖(OR=0.6;95%CI:0.4,0.8)参与者中支气管扩张较少见。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Bronchiectasis is associated with loss of lung function, substantial use of health care resources, and increased morbidity and mortality in people with cardiopulmonary diseases. Purpose To assess the frequency and severity of bronchiectasis and related clinical findings of participants in a low-dose CT (LDCT) screening program. Materials and Methods The Early Lung and Cardiac Action Program (ELCAP) bronchiectasis score (range, 0-42; higher values indicate more severe bronchiectasis) was developed to facilitate bronchiectasis assessment. This quantitative scoring system screened participants based on accumulated knowledge and improved CT imaging capabilities. Secondary review of LDCT studies from smokers aged 40-90 years was performed when they were initially enrolled in the prospective Mount Sinai ELCAP screening study between 2010 and 2019. Medical records were reviewed to identify associated respiratory symptoms and acute respiratory events during the 2 years after LDCT. Logistic regression analysis was performed to examine factors associated with bronchiectasis. Results LDCT studies of 2191 screening participants (mean age, 65 years ± 9; 1140 [52%] women) were obtained, and bronchiectasis was identified in 504 (23%) participants. Median ELCAP bronchiectasis score was 12 (interquartile range, 9-16). Bronchiectasis was most common in the lower lobes for all participants, and lower lobe prevalence was greater with higher ELCAP score (eg, 91% prevalence with an ELCAP score of 16-42). In the fourth quartile, however, midlung involvement was higher compared with lower lung involvement (128 of 131 participants [98%] vs 122 of 131 participants [93%]). Bronchiectasis was more frequent with greater age (odds ratio [OR] = 2.0 per decade; 95% CI: 1.7, 2.4); being a former smoker (OR = 1.33; 95% CI: 1.01, 1.73); and having self-reported chronic obstructive pulmonary disease (OR = 1.38; 95% CI: 1.02, 1.88), an elevated hemidiaphragm (OR = 4; 95% CI: 2, 11), or consolidation (OR = 5; 95% CI: 3, 11). It was less frequent in overweight (OR = 0.7; 95% CI: 0.5, 0.9) or obese (OR = 0.6; 95% CI: 0.4, 0.8) participants. Two years after baseline LDCT, respiratory symptoms, acute respiratory events, and respiratory events that required hospitalization were more frequent with increasing severity of the ELCAP bronchiectasis score (P < .005 for all trends). Conclusion Prevalence of bronchiectasis in smokers undergoing low-dose CT screening was high, and respiratory symptoms and acute events were more frequent with increasing severity of the Early Lung and Cardiac Action Program Bronchiectasis score. © RSNA, 2022 See also the editorial by Verschakelen in this issue.
引用
- Cai, Triphuridet, Zhu, et al. Bronchiectasis in Low-Dose CT Screening for Lung Cancer. Radiology. 2022. PMID: 35438565. doi:10.1148/radiol.212547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。